AI assistant
Sending…
ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2022
May 28, 2022
32464_dirs_2022-05-27_1b407a48-89d1-4ca2-8955-87ca17d4f78a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2022-05-25
Reporting Person: Skarpelos Athanasios (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-25 | Common Stock | M | 50000 | $0.92 | Acquired | 1356458 | Direct |
| 2022-05-25 | Common Stock | S | 50000 | $9.06 | Disposed | 1306458 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-05-25 | Stock Option (Right to Buy) | $0.92 | M | 50000 | Acquired | 2025-04-02 | Common Stock (50000) | Direct |
Footnotes
F1: The options subject to this grant vested quarterly over a three-year period commencing on April 2, 2015.
More from ANAVEX LIFE SCIENCES CORP.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Feb 25
Interim / Quarterly Report
2026
Feb 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Annual Report
2025
Nov 25
Regulatory Filings
2025
Nov 25